Global Regulatory Working Group
Elaine Katrivanos
Vice President, Regulatory Affairs
Tempus AI
Co-Chairs
Jennifer Dickey, PhD
Head of Regulatory and Quality
PGDx
Current Projects
Expanding global usage of BLOODPAC deliverables by modifying, enhancing, or developing new products for global markets.
Identifying and addressing EU-specific challenges to increase patient access to liquid biopsy technology.
Exploring the possibility of hosting an in-person meeting in Brussels to engage with several European organizations and formalize a project.
Deliverable by ESMO 2026: Data Analysis / Landscape paper in collaboration with the Data Science WG
Participating Organizations
AstraZeneca, Bristol Myers Squibb (BMS), Cancer Patients Europe, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), European Liquid Biopsy Society (ELBS), Exact Sciences, Friends of Cancer Research (FOCR), GlaxoSmithKline (GSK), International Quality Network for Pathology (IQN Path), International Society of Liquid Biopsy (ISLB), Johnson & Johnson, Labcorp, MDx CRO, Merck, Natera, Personalis, Tecan, Tempus AI, Thermo Fisher Scientific
Meetings
This working group meets on zoom every other Tuesday from 11:00 - 12:00 PM EST.
Special workshops and sessions:
Not applicable at this time.